Filing Details
- Accession Number:
- 0001179110-19-000467
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-04 18:34:11
- Reporting Period:
- 2019-01-03
- Accepted Time:
- 2019-01-04 18:34:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1280600 | Acceleron Pharma Inc | XLRN | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1690773 | J Habib Dable | 128 Sidney Street Cambridge MA 02139 | Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-01-03 | 1,930 | $43.45 | 66,295 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-01-03 | 27 | $40.85 | 66,268 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.